Medical Oncologist
Sorafenib side effects
Hand-Foot Skin Reaction on Sorafenib: — Prevention From Day One
Hand-foot skin reaction is one of the most common side effects of sorafenib. In its early form it is uncomfortable, not dangerous. Started early, simple skincare can keep it mild. The risk is letting it progress to open sores or pain that stops you walking before you tell your team.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Very common — Hand-foot reaction is one of the most frequently reported side effects of sorafenib.
- Preventable from day one — Starting skincare and footwear protection before your first tablet is more effective than treating it once it appears.
- Dose-limiting, not life-threatening — It is the most common reason sorafenib is paused or reduced, not a danger to your life in its early stages.
- Treatable at every grade — Your team has specific management for mild, moderate and severe reaction — reporting early keeps more options open.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Hand-foot skin reaction happens in a large proportion of people on sorafenib. In its early form it is uncomfortable, not dangerous, and can be kept mild with skincare started on day one. If it progresses to open sores or severe pain that stops you walking, that is the point to call your team the same day.
What can you do at home to stop hand-foot reaction from getting worse?
Start thick, fragrance-free moisturiser before your first sorafenib tablet and apply it to your palms and soles several times a day. Urea-based creams create a better barrier than light lotions. NCCN guidance recommends starting this prevention before treatment begins, not after the reaction appears.
Wear well-fitted, cushioned shoes and thick cotton socks. Avoid walking barefoot on hard floors. Pressure on the ball of the foot, heel, and toes is where the reaction tends to be worst.
Protect your hands during household tasks. Avoid prolonged exposure to hot water. Do not scrub or pumice hardened skin aggressively — that makes the reaction worse.
Do not apply alcohol-based hand sanitiser directly to already-sensitive areas. If you apply cream at night, wearing light cotton gloves or socks over it helps absorption.
How do you know how bad your hand-foot reaction is?
| What to look at | Mild — Grade 1 | Moderate — Grade 2 | Severe — Grade 3 |
|---|---|---|---|
| Skin appearance | Redness, slight thickening, or callus-like patches | Peeling, blisters, or more pronounced thickening | Severe peeling, open sores, or bleeding skin |
| Pain level | None or barely noticeable | Noticeably painful — affects what you can do | Severe pain — stops normal daily tasks |
| Effect on daily life | None — you can do everything as usual | Limits some tasks: walking, gripping, cooking | Cannot walk normally or use hands for basic tasks |
| What to do | Continue prevention; call your team if it is worsening | Call your team within 24 hours; do not wait | Call your team today; do not manage at home alone |
| Typically starts | Usually within the first 2 to 6 weeks of starting sorafenib, on pressure points such as the heel, ball of foot, and fingertips — though it can appear at any point during treatment | — | — |
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Not sure whether this counts as an emergency?
Call the helpline. It is always better to check than to wait.
When should you call your team instead of continuing at home?
Call within 24 hours if your skin has moved from mild redness to pain, or if blisters have appeared. Do not wait for your next scheduled visit.
Your team may pause sorafenib for a week or two to let the skin recover. This is a standard part of managing sorafenib, not a sign that treatment has failed. Many people restart, sometimes at a slightly adjusted dose.
Do not reduce or stop sorafenib on your own. The timing of any pause matters, and that decision belongs with your oncologist.
Did you know?
The skin reaction sorafenib causes is biologically different from the hand-foot syndrome caused by chemotherapy.
Sorafenib targets pressure points with blistering and callus-like thickening, while chemotherapy typically causes generalised redness across the whole palm and sole — which is why the prevention approach is also different.
Source: ESMO Clinical Practice Guidelines — Management of Targeted Therapy Skin Toxicities
Questions patients and families ask most
Is hand-foot reaction a sign that sorafenib is not working against my cancer?
No. Skin reaction is a side effect of how sorafenib works at the cellular level — it is not a signal of how well the drug is working against your tumour. NCCN guidance treats skin toxicity entirely separately from response assessment. Your oncologist will evaluate whether sorafenib is effective through scans and tumour markers on your follow-up schedule, not through what your skin is doing. Do not draw conclusions from one to the other — they are different questions with different answers.
Can I use coconut oil, turmeric paste, or other home remedies on my skin?
Coconut oil is unlikely to cause harm and provides some moisture, but it does not create the same thick barrier as a urea-based cream. Turmeric paste or strongly spiced preparations can irritate already-sensitive skin and should be avoided directly on affected areas. The more important thing is to tell your oncology team everything you are applying to your skin — some substances can mask changes your team needs to see at your next review. Ask before trying something new rather than after.
How long does hand-foot reaction last on sorafenib?
Unlike chemotherapy, which often causes side effects that follow the rhythm of treatment cycles, sorafenib is taken every day, and the reaction can persist throughout treatment. Many people find it settles into a manageable level once they establish a consistent skincare routine and the right footwear. If sorafenib is paused because of a Grade 2 or 3 reaction, the skin usually begins to improve within one to two weeks of the pause, and treatment is typically restarted once it does. Ask your team what timeline to expect for your situation.
Will a dose reduction mean my cancer is less controlled?
Dose reductions for skin toxicity are a planned part of sorafenib management, not a concession. NCCN and ASCO guidance recommends specific dose adjustments for Grade 2 and 3 reactions in order to protect quality of life while keeping treatment going. Many people do well on a dose they can tolerate continuously, compared with a higher dose that forces a full stop. The decision your oncologist makes weighs your skin reaction against how you are responding to treatment — they will explain the reasoning specific to your situation.
My feet look red and thickened but feel fine. Should I still mention it?
Yes, it is worth mentioning at your next visit, or sooner if it is changing quickly. Grade 1 reaction — redness and thickening without pain — is the easiest point at which to prevent progression. If your team knows what your skin looks like now, they can spot early worsening and adjust your prevention plan before it becomes painful. Taking a clear photograph of the affected areas on your phone is a practical way to track changes between visits and show your team exactly what you have noticed.
Explore 100 more Gastrointestinal & Liver Targeted Medicines topics
Drug Deep Dive: Sorafenib (Nexavar)
- Blood Pressure, Rash and Hair Thinning on Sorafenib
- Diarrhoea on Sorafenib: Controlling It Without Stopping Treatment
- Diet and Nutrition While on Sorafenib
- Drug, Food and Supplement Interactions With Sorafenib
- Fertility, Pregnancy and Contraception on Sorafenib
- Hand-Foot Skin Reaction on Sorafenib: Prevention From Day One
- How Does Sorafenib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sorafenib Take to Work?
- How Long Will You Stay on Sorafenib?
- Sorafenib (Nexavar, Soranib): The Complete Patient Guide
- Sorafenib Myths: Dose Reduction, 'Last Resort' and Generic Quality
- Sorafenib Price in India: Brand, Generic and Monthly Cost
- Sorafenib Side Effects: The Complete List and Timeline
- Sorafenib Success Rate and Survival: An Honest Look at the Numbers
- Sorafenib With Cirrhosis: Why Child-Pugh Status Decides Eligibility
- Sorafenib With TACE and Other Liver-Directed Treatments
- Sorafenib in Elderly Patients and Those With Other Illnesses
- Sorafenib in Liver, Kidney and Thyroid Cancer: Three Different Uses
- Sorafenib vs Lenvatinib for Liver Cancer: Cost, Tolerability and Evidence
- Taking Sorafenib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sorafenib
- When Sorafenib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sorafenib? Liver, Kidney and Radioiodine-Refractory Thyroid Cancer
- Will Insurance or a Government Scheme Pay for Sorafenib?
- Work, Travel and Daily Life on Sorafenib
Drug Deep Dive: Bevacizumab (Avastin)
- Avastin vs Biosimilar Bevacizumab in India: Cost and Safety
- Bevacizumab (Avastin and biosimilars): The Complete Patient Guide
- Bevacizumab Infusion Day: Premedication, Duration and What to Expect
- Bevacizumab Myths: 'It Dissolves Tumours' and Other Misconceptions
- Bevacizumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Bevacizumab Side Effects: The Complete List and Timeline
- Bevacizumab Success Rate and Survival: An Honest Look at the Numbers
- Bevacizumab With Chemotherapy: Which Combinations and Why
- Bevacizumab in Elderly Patients and Those With Other Illnesses
- Bevacizumab in Eye Disease vs Cancer: Same Drug, Very Different Dose
- Bleeding, Bowel Perforation and Wound Healing Risks on Bevacizumab
- Diet and Nutrition While on Bevacizumab
- Drug, Food and Supplement Interactions With Bevacizumab
- Fertility, Pregnancy and Contraception on Bevacizumab
- High Blood Pressure on Bevacizumab: Monitoring and Treatment
- How Does Bevacizumab Work? The Anti-VEGF Angiogenesis Inhibitor Explained
- How Long Does Bevacizumab Take to Work?
- How Long Will You Stay on Bevacizumab?
- Protein in Your Urine on Bevacizumab: What the Report Means
- Surgery While on Bevacizumab: The 28-Day Rule
- Tests and Monitoring While You Are on Bevacizumab
- When Bevacizumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Bevacizumab? Colorectal, Lung, Ovarian, Cervical and Brain Cancer
- Will Insurance or a Government Scheme Pay for Bevacizumab?
- Work, Travel and Daily Life on Bevacizumab
Drug Deep Dive: Cetuximab (Erbitux)
- Cetuximab (Erbitux): The Complete Patient Guide
- Cetuximab Infusion Day: Premedication, Duration and What to Expect
- Cetuximab Infusion Reactions: Why the First Dose Is Given Slowly
- Cetuximab Myths: 'The Worse the Rash, the Better' and Other Half-Truths
- Cetuximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Cetuximab Side Effects: The Complete List and Timeline
- Cetuximab Success Rate and Survival: An Honest Look at the Numbers
- Cetuximab With FOLFIRI, FOLFOX and Radiation
- Cetuximab in Colorectal vs Head and Neck Cancer: Different Roles
- Cetuximab in Elderly Patients and Those With Other Illnesses
- Cetuximab vs Bevacizumab in Colorectal Cancer: Which and When
- Diet and Nutrition While on Cetuximab
- Drug, Food and Supplement Interactions With Cetuximab
- Fertility, Pregnancy and Contraception on Cetuximab
- How Does Cetuximab Work? The Anti-EGFR Monoclonal Antibody Explained
- How Long Does Cetuximab Take to Work?
- How Long Will You Stay on Cetuximab?
- Low Magnesium on Cetuximab: Cramps, Fatigue and Monthly Testing
- Tests and Monitoring While You Are on Cetuximab
- The Cetuximab Rash: Severity, Treatment and Why It Predicts Response
- When Cetuximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Cetuximab? RAS Wild-Type Colorectal Cancer and Head and Neck Cancer
- Why Cetuximab Only Works in RAS Wild-Type, Left-Sided Tumours
- Will Insurance or a Government Scheme Pay for Cetuximab?
- Work, Travel and Daily Life on Cetuximab
Drug Deep Dive: Lenvatinib (Lenvima)
- Blood Pressure Spikes on Lenvatinib: The Critical First Two Weeks
- Diarrhoea, Appetite Loss and Rapid Weight Drop on Lenvatinib
- Diet and Nutrition While on Lenvatinib
- Dose Reductions on Lenvatinib: Why Most Patients Need One
- Drug, Food and Supplement Interactions With Lenvatinib
- Fertility, Pregnancy and Contraception on Lenvatinib
- Hand-Foot Skin Reaction on Lenvatinib: Prevention and Relief
- How Does Lenvatinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Lenvatinib Take to Work?
- How Long Will You Stay on Lenvatinib?
- Lenvatinib (Lenvima, Lenvanix): The Complete Patient Guide
- Lenvatinib Myths: Side Effects, Dose Cuts and 'Giving Up'
- Lenvatinib Price in India: Brand, Generic and Monthly Cost
- Lenvatinib Side Effects: The Complete List and Timeline
- Lenvatinib Success Rate and Survival: An Honest Look at the Numbers
- Lenvatinib With Immunotherapy: The Combination Explained
- Lenvatinib for Radioactive-Iodine-Refractory Thyroid Cancer
- Lenvatinib in Elderly Patients and Those With Other Illnesses
- Lenvatinib vs Sorafenib for Liver Cancer: Which Comes First?
- Taking Lenvatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Lenvatinib
- When Lenvatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Lenvatinib? Liver, Thyroid, Kidney and Endometrial Cancer
- Will Insurance or a Government Scheme Pay for Lenvatinib?
- Work, Travel and Daily Life on Lenvatinib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
What does hand-foot skin reaction feel like when it first starts on sorafenib?
It often begins as warmth, tingling, or mild redness on the palms and soles — particularly over pressure points like the ball of the foot, heel, and fingertips. Some people notice a sensation before any visible skin change appears. The reaction can progress to thickened, callus-like patches, and then to painful blisters if it is not managed. Starting moisturiser and protective footwear before these early signs appear, rather than waiting until it is painful, is the most effective approach according to NCCN guidance.
Can hand-foot reaction from sorafenib be prevented completely?
Prevention cannot guarantee the reaction will not appear, but it can significantly reduce how severe it becomes. Starting a thick, urea-based moisturiser and cushioned footwear before your first sorafenib tablet is the approach recommended by NCCN and ESMO guidelines. Many people who begin prevention early experience only mild or manageable symptoms throughout treatment. What skincare alone cannot prevent, your team can manage through dose adjustment — but early reporting is what keeps those options available.
What kind of moisturiser should I use for hand-foot reaction on sorafenib?
Thick, fragrance-free creams containing urea are what NCCN guidance points to for sorafenib-related skin reactions. Lighter lotions do not create the same protective barrier. Apply generously to palms and soles several times a day, and if you can tolerate it, wear cotton socks or light cotton gloves over the cream overnight to help absorption. Ask your oncology nurse or pharmacist to recommend a specific urea cream available in your area — they are widely stocked in Indian pharmacies and come in several strengths.
Will sorafenib need to be stopped permanently because of hand-foot reaction?
Most people do not need to stop permanently. For Grade 2 reaction, NCCN guidance supports pausing sorafenib and restarting once the skin recovers, sometimes at an adjusted dose. Permanent stopping is usually only considered when the reaction is severe, recurrent, and cannot be controlled at any dose the person can tolerate. Reporting symptoms early keeps more management options available — dose adjustments made at Grade 2 are considerably easier to navigate than a full interruption caused by Grade 3.
Is sorafenib hand-foot reaction the same as hand-foot syndrome from chemotherapy?
They share a name and location but are different conditions. Chemotherapy-related hand-foot syndrome causes generalised redness and tenderness spread across the whole palm and sole. Sorafenib causes a more focal reaction, with thickened, callus-like patches and blisters concentrated at pressure points — which is why cushioned footwear matters particularly on sorafenib, and why advice given for chemotherapy hand-foot syndrome may not be the right guidance for you. Tell your team specifically that you are on sorafenib if you ask for advice elsewhere.